Abstract
Outcome of 333 children with acute myeloid leukaemia relapsing after a first allogeneic haematopoietic stem cell transplantation was analyzed. Four-year probability of overall survival (4y-pOS) was 14%. 4y-pOS for 122 children receiving a second haematopoietic stem cell transplantation was 31% and 3% for those that did not (P = <0·0001). Achievement of a subsequent remission impacted survival (P = <0·0001). For patients receiving a second transplant survival with or without achieving a subsequent remission was comparable. Graft source (bone marrow vs. peripheral blood stem cells, P = 0·046) and donor choice (matched family vs. matched unrelated donor, P = 0·029) positively impacted survival after relapse. Disease recurrence and non-relapse mortality at four years reached 45% and 22%.
Lingua originale | English |
---|---|
pagine (da-a) | 745-750 |
Numero di pagine | 6 |
Rivista | British Journal of Haematology |
Volume | 189 |
DOI | |
Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- acute myeloid leukemia
- allogeneic hematopoietic stem cell transplantation
- second hematopoietic stem cell transplantation
- relapse
- children